TrAMPoline Pharma is a cutting-edge cellular immunotherapy company that is committed to advancing the fight against cancer. Our team of experts is dedicated to developing the next generation of cancer therapies. We are actively seeking investors to help us bring our innovative technologies to market and make a meaningful impact in the lives of cancer patients.

A panel of experts chose TrAMPoline Pharma to present at the 2024 Rocky Mountain Life Sciences Investor & Partnering Conference in Breckenridge on September 12 and 13. The presenting companies represent the ‘best of the Rocky Mountain West’ with leading-edge health innovations from Colorado and surrounding states. The conference connects investors and strategic partners from across the U.S. with the region’s most promising startup, emerging, and growth companies. More on the Conference: https://cobioscience.com/networking-events/rocky-mountain-life-sciences-investor-partnering-conference-2024/

Join our CSO Dr. Davila who is an invited speaker at the 6th Annual TIL Therapies Summit for multiple important discussions about TIL development: 1) aligning industry and academia to accelerate TIL breakthroughs, 2) considerations for increasing TIL treatment capacity, and 3) lowering activation thresholds for TIL therapies. More on the conference: https://til-therapies.com/